Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 26, 2024
Pharmacodynamic and pharmacokinetic profiles of a novel GLP-1 receptor biased agonist-SAL0112
Jingchao Sun, Ying Xiao, Wei Xing, et al.
Expert Opinion on Investigational Drugs
|
October 11, 2021
A randomized, double-blind, placebo-controlled, single, and multiple dose-escalation Phase I clinical trial to investigate the safety, pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers
Yue Hu, Hong Zhang, Xiaojiao Li, et al.
Immunotherapy
|
January 10, 2024
SAFFRON-103: a phase Ib study of sitravatinib plus tislelizumab in anti-PD-(L)1 refractory/resistant advanced melanoma
Xuan Wang, Hongming Pan, Jiuwei Cui, et al.
Journal of Child and Adolescent Psychopharmacology
|
July 3, 2020
Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder
Deborah Winders Davis, Yana Feygin, Liza Creel, et al.
Clinical Pharmacology in Drug Development
|
October 10, 2023
Pharmacokinetics and Drug-Drug Interaction of Allisartan Isoproxil and Indapamide Sustained-Release Formulation
Wu Yi, Sisi Lin, Rui Hao, et al.
Nutrients
|
February 26, 2025
Alteration of Gastrointestinal Function and the Ameliorative Effects of <i>Hericium erinaceus</i> Polysaccharides in Tail Suspension Rats
Peng Zang, Pu Chen, Junli Chen, et al.
Clinical Pharmacology in Drug Development
|
July 9, 2021
Pharmacokinetics and Safety of a Single Dose and Multiple Doses of Allisartan Isoproxil, an Angiotensin II Receptor Blocker, in Healthy Chinese People
Wu Yi, Peiyuan Yan, Sisi Lin, et al.
BMC Medicine
|
October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial
Mingtong Xu, Kan Sun, Wenjie Xu, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 26, 2024
Pharmacodynamic and pharmacokinetic profiles of a novel GLP-1 receptor biased agonist-SAL0112
Jingchao Sun, Ying Xiao, Wei Xing, et al.
Expert Opinion on Investigational Drugs
|
October 11, 2021
A randomized, double-blind, placebo-controlled, single, and multiple dose-escalation Phase I clinical trial to investigate the safety, pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers
Yue Hu, Hong Zhang, Xiaojiao Li, et al.
Immunotherapy
|
January 10, 2024
SAFFRON-103: a phase Ib study of sitravatinib plus tislelizumab in anti-PD-(L)1 refractory/resistant advanced melanoma
Xuan Wang, Hongming Pan, Jiuwei Cui, et al.
Journal of Child and Adolescent Psychopharmacology
|
July 3, 2020
Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder
Deborah Winders Davis, Yana Feygin, Liza Creel, et al.
Clinical Pharmacology in Drug Development
|
October 10, 2023
Pharmacokinetics and Drug-Drug Interaction of Allisartan Isoproxil and Indapamide Sustained-Release Formulation
Wu Yi, Sisi Lin, Rui Hao, et al.
Nutrients
|
February 26, 2025
Alteration of Gastrointestinal Function and the Ameliorative Effects of <i>Hericium erinaceus</i> Polysaccharides in Tail Suspension Rats
Peng Zang, Pu Chen, Junli Chen, et al.
Clinical Pharmacology in Drug Development
|
July 9, 2021
Pharmacokinetics and Safety of a Single Dose and Multiple Doses of Allisartan Isoproxil, an Angiotensin II Receptor Blocker, in Healthy Chinese People
Wu Yi, Peiyuan Yan, Sisi Lin, et al.
BMC Medicine
|
October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial
Mingtong Xu, Kan Sun, Wenjie Xu, et al.
Page
of 4